Center for Genomic Interpretation Podcast Highlights Role of Variant Classification Analysis and Guidelines In Precision Medicine Madhuri Hegde, PhD Identifies Several Key Challenges Associated with Next Generation Sequencing and Stresses Importance of Collaboration...
Introduction On The Rising Tide Podcast, scientists from the independent, nonprofit Center for Genomic Interpretation discuss with leading experts the need to further raise the bar on accuracy and quality in clinical genetics, genomics, and precision medicine. Only...
Center for Genomic Interpretation Launches Rising Tide Podcast Series Educational Programs to Focus on Challenges and Opportunities Associated with Precision Medicine Annapolis, MD / PRWeb / August 3, 2021 – The Center for Genomic Interpretation (CGI) recently...
Center for Genomic Interpretation Launches ELEVATEGENETICS BRILLIANT Program™Innovative technical competency assessment is a game changer in evaluating the accuracy of genetic and genomic lab testing and results reporting Annapolis, MD / PRWeb / May 27, 2021 – The...
When a healthcare provider orders a genetic or genomic test for a patient, the patient's sample (blood, saliva, or tissue) is sent to a genetic testing laboratory, and then a report comes back indicating the presence or absence of genetic variants in the patient...
Over a Friday and Saturday in late April 2021, genetic counselors from every hospital genetics program across Utah volunteered their time to participate in a film shoot for clinician education videos that will be launched in late summer 2021 on the TestWisely.org...
CGI’s co-founder and CEO, Dr. Julie Eggington, was a winner of a 2019 Sego Award in Innovation in Technology as a leader in Utah’s business community, a unique accomplishment for the leader of a nonprofit organization. She was recently interviewed by Salt Lake City’s...
“Aligning Genetic and Genomic Test Reimbursement With Value of Tests” is an invited article just published in Clinical Laboratory News of the American Association for Clinical Chemistry, authored by CGI’s Drs. Eggington and Garlapow. They summarize issues with...
CGI’s co-founder, Dr. Julie Eggington, and CGI’s ELEVATEGENETICS Standards Committee member, Dr. John Pfeifer, were interviewed by the American Society of Hematology for their article “Demystifying DNA Variant Reporting”, published on December 1, 2020. Dr. Pfeifer...
CGI presented its work on how pathogenic variant classifications are not always well-supported by evidence. Working together with genetic counselors from Rocky Mountain Cancer Centers and Texas Oncology, CGI collected de-identified patient reports and examined the...